Project Details
Description
A Phase 1/2 Trail of Enzastaurin and Erlotinib in Patients with Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) after Prior Chemotherapy
| Status | Finished |
|---|---|
| Effective start/end date | 8/21/07 → 9/15/11 |
Funding
- ELI LILLY AND COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.